ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2457
0,00%
Bitcoin
69.019,56
1,88%
Brent Oil
81,295
0,61%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Rosetta Genomics Ltd (CE) (ROSGQ)

  7. Rosetta Genomics Ltd (CE) (ROSGQ) Notícias

ROSGQ

Rosetta Genomics (CE) (ROSGQ)

Rosetta Genomics Ltd (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:ROSGQ
DataHoraFonteTítuloCódigoCompanhia
22/04/201914:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ROSGQRosetta Genomics Ltd (CE)
04/01/201913:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ROSGQRosetta Genomics Ltd (CE)
19/07/201810:05Edgar (US Regulatory)(25-NSE)USOTC:ROSGQRosetta Genomics Ltd (CE)
18/05/201813:45Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:ROSGQRosetta Genomics Ltd (CE)
01/05/201817:07Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:ROSGQRosetta Genomics Ltd (CE)
14/03/201816:09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ROSGQRosetta Genomics Ltd (CE)
12/03/201811:55Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ROSGQRosetta Genomics Ltd (CE)
30/10/201708:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ROSGQRosetta Genomics Ltd (CE)
16/10/201719:25Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)USOTC:ROSGQRosetta Genomics Ltd (CE)
07/08/201709:51Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)USOTC:ROSGQRosetta Genomics Ltd (CE)
07/08/201709:49Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:ROSGQRosetta Genomics Ltd (CE)
02/08/201717:04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)USOTC:ROSGQRosetta Genomics Ltd (CE)
25/04/201718:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ROSGQRosetta Genomics Ltd (CE)
30/03/201707:04Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:ROSGQRosetta Genomics Ltd (CE)
16/02/201720:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ROSGQRosetta Genomics Ltd (CE)
28/11/201619:49Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:ROSGQRosetta Genomics Ltd (CE)
30/03/201618:58Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:ROSGQRosetta Genomics Ltd (CE)
23/03/201617:46Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)USOTC:ROSGQRosetta Genomics Ltd (CE)
04/03/201618:06Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ROSGQRosetta Genomics Ltd (CE)
14/10/201514:17Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)USOTC:ROSGQRosetta Genomics Ltd (CE)
30/09/201510:15GlobeNewswire Inc.Rosetta Genomics to Partner with FNApath to Provide Centralized Laboratory Testing Services for Thyroid CancerUSOTC:ROSGQRosetta Genomics Ltd (CE)
02/06/201518:01InvestorsHub NewsWireUS MILITARY ACCIDENTALLY SHIPS LIVE ANTHRAX VIA FEDEX; THESE ARE THE STOCKS TO WATCH IN ITS WAKEUSOTC:ROSGQRosetta Genomics Ltd (CE)
30/04/201506:59Analyst Ratings NetworkRosetta Genomics Earns Outperform Rating from Analysts at Barrington Research (ROSG)USOTC:ROSGQRosetta Genomics Ltd (CE)
26/06/201410:43MarketwiredRosetta Genomics Receives Notice of Allowance for U.S. Patent for the Prognosis and Treatment of Prostate CancerUSOTC:ROSGQRosetta Genomics Ltd (CE)
09/06/201409:10MarketwiredUPDATE: Rosetta Genomics & Moffitt Cancer Center Enter Into Agreement to Advance Development of microRNA-Based Cancer Diagnos...USOTC:ROSGQRosetta Genomics Ltd (CE)
09/06/201408:02MarketwiredRosetta Genomics and Moffitt Cancer Center Enter Into Agreement to Advance Development of microRNA-Based Cancer DiagnosticUSOTC:ROSGQRosetta Genomics Ltd (CE)
04/04/201409:15MarketwiredRosetta Genomics to Receive U.S. Patent for Cancer Origin AssayUSOTC:ROSGQRosetta Genomics Ltd (CE)
02/04/201410:08MarketwiredRosetta Genomics & Marina Biotech Establish Strategic Alliance to Jointly Develop microRNA-Based Diagnostics & Therapeutics f...USOTC:ROSGQRosetta Genomics Ltd (CE)
31/03/201419:05MarketwiredRosetta Genomics Reports 2013 Financial ResultsUSOTC:ROSGQRosetta Genomics Ltd (CE)
25/03/201415:50MarketwiredRosetta Genomics to Host Business Update Conference Call on April 1, 2014USOTC:ROSGQRosetta Genomics Ltd (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:ROSGQ

Seu Histórico Recente

LSE
FNT
USOTC
MTAM
Motos America (CE)
EU
SEMAN
Semapa Semap1734%22apr32
USOTC
WDCTF
Wildcat Resources (PK)
TSXV
CLN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados